Warren Buffett: leans back in his chair "Well, we've all looked at NKE. Let me start with the big question—if we had to hold this business for 20 years, would we sleep well at night? Not based on today's stock price, but based on the fundamental durability of that Swoosh."

Charlie Munger: "That depends entirely on whether we're witnessing temporary indigestion or permanent decay. The brand isn't dead—kids still want Jordans. But I'm seeing classic signs of incentive-caused bias in their DTC strategy. They pushed too hard on direct channels, alienated wholesale partners like Foot Locker, and now they're scrambling to rebuild those relationships. That's reversible, not terminal."

Dev Kantesaria: "Charlie, I respect that view, but you're missing the structural shift. Nike's success used to feel inevitable—like Coca-Cola or See's Candies. Now it feels conditional. The bear case that keeps me up at night is that Nike becomes the next Gap: a brand that everyone recognizes but nobody craves. When I walk through malls, I see On Running stores packed with 30-50 year olds paying premium prices for performance running shoes. Nike's innovation pipeline hasn't produced a category-defining product since Flyknit a decade ago."

Robert Vinall: "Dev makes a fair point about innovation, but let me push back on the Gap comparison. Gap lost its cultural relevance because it stopped meaning anything specific. Nike still means athletic performance and cultural coolness. The real question is: can they maintain that dual identity? The Jordan brand alone does $5 billion annually—that's not a business in terminal decline. It's a bit like Disney's Marvel franchise: periodically mismanaged but fundamentally valuable."

David Tepper: "Robert, I'm not so sure. What worries me is the simultaneous decline across multiple geographies and channels. In the transcript, Hill mentions 'rightsizing our classics business'—that's corporate speak for 'we overproduced basic shoes and now we're discounting.' When a premium brand starts discounting, it's like watching a great athlete lose their first step. It might not come back."

Mohnish Pabrai: "David nailed it. I'm looking for asymmetric bets—heads I win big, tails I don't lose much. Here, the downside isn't limited. If Nike's China business continues declining at 16% and margins compress further, this could be a value trap. I'm reminded of Heinz before Buffett bought it—great brand, but stuck in a structural decline with private label taking share. The risk-reward isn't there."

Pulak Prasad: "Mohnish, your asymmetry framework is sound, but let me offer an evolutionary perspective. Nike has survived 60 years through multiple cycles—the aerobics craze, Reebok's rise, Under Armour's challenge. The brands that survive aren't the ones that never stumble; they're the ones that adapt. Management acknowledges they need to 'rightsize' and 'build momentum'—that's adaptation language. The question is whether they're adapting fast enough."

Warren Buffett: "So we're divided on whether this is a stumble or a fracture. Let me ask specifically about competition: who here believes On Running or Hoka can actually take meaningful market share from Nike in the long run? Not just niche products, but truly challenge the empire?"

Charlie Munger: "Warren, that's the right question. The answer is no—not in the way that Android challenged iPhone. These are specialty players. On Running is the modern-day version of Brooks—great for serious runners, but not a threat to the broad athletic ecosystem. Nike's scale in marketing, athlete endorsements, and global distribution creates a moat that's expensive to cross. The problem isn't competition taking share; it's Nike giving it away through poor execution."

Dev Kantesaria: "Charlie, I have to disagree. Look at what happened to Nike in basketball—their signature sport! They lost the NBA uniform deal to Fanatics and Jordan Brand is losing ground to Stephen Curry's Under Armour line and even New Balance with Kawhi Leonard. When you lose authority in your core categories, that's not 'poor execution'—that's moat erosion. It's exactly what happened to Intel when AMD started making better chips."

Robert Vinall: "Dev, you're citing real concerns, but let's not extrapolate temporary setbacks into permanent decline. Nike still has LeBron, still has the Olympics, still has Drake designing NOCTA products. The cultural relevance is still there—the financials just haven't caught up yet. This reminds me of Apple in 2016 when everyone said they'd lost innovation. Then they launched AirPods and services took off. Great brands have reservoirs of trust they can draw upon."

David Tepper: "Robert, I appreciate the optimism, but let's look at what management is actually saying. In the transcript, Hill thanks the team for 'steady progress and building momentum' while simultaneously talking about 'rightsizing.' That's contradictory language. When I hear 'rightsizing,' I think inventory write-downs and margin pressure. This isn't Apple 2016; it's more like Best Buy 2012—a good company facing structural headwinds from changing consumer habits."

Mohnish Pabra: "David's right about the language. But more importantly, where's the catalyst? For this to be a good investment, we need to see either revenue reacceleration or margin expansion. Right now we have neither. The transcript mentions China declining 16%—that's not a temporary blip, that's a structural shift toward Li-Ning and Anta. I'd rather wait until we see concrete signs of turnaround rather than hope for one."

Pulak Prasad: "Mohnish, your caution is warranted, but evolution doesn't happen in straight lines. Nike's China problems are partly geopolitical—that's external and potentially reversible. Meanwhile, they're gaining share in India and other emerging markets. The Darwinian test isn't whether a species survives every environment; it's whether it adapts to new ones. Nike has proven that ability multiple times over decades."

Warren Buffett: "Alright, we've debated the qualitative story thoroughly. Now let's turn to the numbers. What does the 10-year financial history tell us about whether this moat is durable or deteriorating?"

Charlie Munger: "The numbers tell a clear story of a great business that's hit a rough patch. For a decade, Nike consistently generated over 20% return on invested capital. That's the sign of a powerful moat. But the recent drop to 10.9% ROIC is alarming. Either this is temporary—due to inventory overload and COVID hangover—or it's permanent. I lean toward temporary, but I want to see the proof."

Dev Kantesaria: "Charlie, I wish I shared your optimism. The financials show something more concerning: revenue growth has slowed from high single digits to low single digits while margins have compressed from 13-14% to 7.4%. That's the opposite of what should happen with scale. It suggests either pricing power erosion or cost structure inflation—both bad signs. This pattern reminds me of Procter & Gamble in the 2010s: still shipping volume, but losing profitability to private label."

Robert Vinall: "Dev, you're looking at the wrong time frame. If you zoom out, Nike has grown revenue from $25 billion to $46 billion over 10 years—that's 6-7% annual growth, which is respectable for a company this size. The margin compression is concerning, but part of that is investment in DTC and digital. The question is whether those investments will pay off. If they can get margins back to 10-11%, the earnings power is still there."

David Tepper: "Robert, 'if they can get margins back' is doing a lot of work there. The operating margin dropped from 12.5% to 7.4% in just two years. That's a $2.5 billion annual earnings hit. When I see that kind of margin compression, I think either permanent competitive pressure or terrible capital allocation. Given their inventory buildup and DTC missteps, I lean toward the latter. This isn't investment; it's inefficiency."

Mohnish Pabrai: "David's math is correct, and it highlights the asymmetry problem. At current valuations, the market is pricing in a margin recovery. If margins don't recover, earnings could stay depressed around $3-4 per share instead of the historical $5-6. That means significant downside from here. I'm not being paid enough to take that risk."

Pulak Prasad: "But look at the free cash flow: still generating over $3 billion annually even in this depressed state. That's the sign of a durable business. They're not burning cash like a startup; they're generating substantial cash even while struggling. That financial resilience is what allowed Coca-Cola to survive their New Coke disaster and IBM to survive the PC wars."

Warren Buffett: "Now let's talk valuation. The stock sits at $65 today. Who here would buy at this price, and who would avoid?"

Dev Kantesaria: "I'm avoiding. At 33x depressed earnings, you're paying for a recovery that may not come. If this is structural decline, the multiple could compress to 15-20x earnings. I'd need to see ROIC sustainably back above 15% before I'd consider it."

David Tepper: "Avoid. No catalyst for improvement visible, and simultaneous pressure on both revenue and margins. This could easily drop to $45-50 if next quarter disappoints. I'd rather wait for clear signs of turnaround."

Mohnish Pabrai: "Avoid. The risk-reward doesn't work for me. I'm risking $65 to maybe make $85 if everything goes right, or lose $20-30 if it doesn't. That's not the 10-to-1 asymmetry I look for."

Robert Vinall: "I'd buy, but lower. Around $55, which would be about 25x depressed earnings. That price would build in enough margin of safety for the execution risk while still capturing the long-term brand value."

Pulak Prasad: "I'd also buy lower—around $60 for me. The evolutionary resilience is there, but current management needs to prove they can navigate this transition."

Charlie Munger: "I'm with Robert—$55 would interest me. That's a price that acknowledges the problems but doesn't require perfection to work out."

Warren Buffett: "And I'd be a buyer around $55 as well. You're paying 20-25x earnings for a business that, if it solves its execution problems, could earn $4-5 per share in a normalized environment."

Warren Buffett: surveys the room "Let me try to synthesize where we've landed after this discussion. On the qualitative side, we broadly agree that Nike's brand reservoir hasn't been drained—the Swoosh still means something powerful in sport and culture. That's not nothing. As I learned with See's Candies, when customers ask for your product by name rather than the category, you've got something special.

But here's where we diverge: Dev, David, and Mohnish see a business that's losing its compounding characteristics. The 16% decline in China, the margin compression from 12.5% to 7.4%, the innovation gap versus On Running and Hoka—these look like structural threats rather than cyclical issues. They're worried this is the next Procter & Gamble: still shipping volume but losing pricing power.

Charlie, Robert, Pulak and I see it differently. We see specific, reversible errors: the DTC overreach that alienated wholesale partners, the inventory glut from COVID optimism, the management turnover. Elliott Hill's return as CEO reminds me of Howard Schultz coming back to Starbucks—a proven operator who knows where the bodies are buried.

On valuation, at $65, you're paying 33x depressed earnings for a turnaround story. If margins recover to 10%—still below historical levels—you get to $4-5 EPS and a stock worth $80-90. But if the bears are right, you're catching a falling knife.

The majority of us would buy around $55 or lower—a price that doesn't require heroic assumptions. That's where we land: four would buy lower, three would avoid entirely. Reasonable people can disagree on whether Nike's problems are cyclical or structural, and on this one, they do."